OpGen, Inc. (OPGN) got here out with a quarterly lack of $3.34 per share versus the Zacks Consensus
OpGen, Inc. (OPGN) got here out with a quarterly lack of $3.34 per share versus the Zacks Consensus Estimate of a lack of $2.60. This compares to lack of $10.60 per share a yr in the past. These figures are adjusted for non-recurring objects.
This quarterly report represents an earnings shock of -28.46%. 1 / 4 in the past, it was anticipated that this firm would submit a lack of $3.20 per share when it truly produced a lack of $3, delivering a shock of 6.25%.
Over the past 4 quarters, the corporate has surpassed consensus EPS estimates simply as soon as.
OpGen, Inc.Which belongs to the Zacks Medical Companies business, posted revenues of $0.65 million for the quarter ended September 2019, lacking the Zacks Consensus Estimate by 28%. This compares to year-ago revenues of $0.55 million. The corporate has topped consensus income estimates simply as soon as over the past 4 quarters.
The sustainability of the inventory’s instant value motion primarily based on the recently-released numbers and future earnings…